Source: American Journal of Nephrology. Unidade: FMRP
Subjects: BIOMARCADORES, INSUFICIÊNCIA RENAL CRÔNICA, METALOPROTEINASES, POLIMORFISMO, ESTUDOS DE CASOS E CONTROLES
ABNT
MARSON, Bernardo P. et al. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease. American Journal of Nephrology, v. 35, n. 3, p. 209-215, 2012Tradução . . Disponível em: https://doi.org/10.1159/000336108. Acesso em: 25 ago. 2024.APA
Marson, B. P., Lacchini, R., Belo, V., Dickel, S., Costa, B. P. da, Figueiredo, C. E. P. de, & Tanus-Santos, J. E. (2012). Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease. American Journal of Nephrology, 35( 3), 209-215. doi:10.1159/000336108NLM
Marson BP, Lacchini R, Belo V, Dickel S, Costa BP da, Figueiredo CEP de, Tanus-Santos JE. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease [Internet]. American Journal of Nephrology. 2012 ; 35( 3): 209-215.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1159/000336108Vancouver
Marson BP, Lacchini R, Belo V, Dickel S, Costa BP da, Figueiredo CEP de, Tanus-Santos JE. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease [Internet]. American Journal of Nephrology. 2012 ; 35( 3): 209-215.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1159/000336108